Experimental infection and protection against ... - TI Pharma
Experimental infection and protection against ... - TI Pharma Experimental infection and protection against ... - TI Pharma
Induction of malaria in volunteers by intradermal injection of cryopreserved Plasmodium falciparum sporozoites 14. Thompson FM, Porter DW, Okitsu SL, et al. Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial. PLoS One 2008; 3:e1493. 15. Kester KE, Cummings JF, Ofori-Anyinam O, et al. Randomized, Double-Blind, Phase 2a Trial of falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection. J Infect Dis 2009; 200:337-46. 16. Beadle C, Long GW, Weiss WR, et al. Diagnosis of malaria by detection of Plasmodium falciparum HRP-2 antigen with a rapid dipstick antigen-capture assay. Lancet 1994; 343:564-568. 17. McCall MB, Netea MG, Hermsen CC, et al. Plasmodium falciparum infection causes proinflammatory priming of human TLR responses. J Immunol 2007; 179:162-71. 18. Clyde DF, McCarthy VC, Miller RM, Woodward WE. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am J Trop Med Hyg 1975; 24:397-401. 19. Rieckmann KH, Carson PE, Beaudoin RL, Cassells JS, Sell KW. Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans R Soc Trop Med Hyg 1974; 68:258-9. 20. Hoffman SL, Goh LM, Luke TC, et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 2002; 185:1155-64. 21. Roestenberg M, McCall M, Hopman J, et al. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 2009; 361:468-77. 22. Roestenberg M, Teirlinck AC, McCall MB, et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 2011; 377:1770-6. 23. Maynes B. The injection of mosquito sporozoites in malaria therapy. Pub Health Rep 1933;48:909-13. 24. Mayne B, Young M. The technique of induced malaria as used in the South Carolina State Hospital. Journal of Venereal Disease Information 1941; 22:271- 6. 25. Jeffery GM, Rendtorff RC. Preservation of viable human malaria sporozoites by low-temperature freezing. Exp Parasitology 1955; 4:445-54. 26. Glynn JR, Bradley DJ. Inoculum size, incubation period and severity of malaria. Analysis of data from malaria therapy records. Parasitology 1995; 110:7-19. 27. Hoffman SL, Billingsley PF, James E, et al. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccin 2010; 6:97-106. 167
168 Chapter 8 28. Epstein JE, Tewari K, Lyke KE, et al. Live attenuated malaria vaccine designed to protect through hepatic CD8 T cell immunity. Science 2011; 334:475-480. 29. Church LW, Le TP, Bryan JP, et al. Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. J Infect Dis 1997; 175:915-20. 30. Verhage DF, Telgt DS, Bousema JT, et al. Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes. Neth J Med 2005; 63:52-8. 31. Epstein JE, Rao S, Williams F, et al. Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update. J Infect Dis 2007; 196:145-54. 32. Rickman LS, Jones TR, Long GW, et al. Plasmodium falciparum-infected Anopheles stephensi inconsistently transmit malaria to humans. Am J Trop Med Hyg 1990; 43:441-5. 33. Lyke KE, Laurens M, Adams M, et al. Plasmodium falciparum malaria challenge by the bite of aseptic Anopheles stephensi mosquitoes: results of a randomized infectivity trial. PLoS One 2010; 5:e13490. 34. Inoue M & Culleton RL The intradermal route for inoculation of sporozoites of rodent malaria parasites for immunological studies. Parasite Immunol. 2011; 33:137-142. 35. Fairley NH. Sidelights on malaria in man obtained by subinoculation experiments. Trans R Soc Trop Med Hyg 1947; 40:621-76. 36. Alonso PL, Djimde A, Kremsner P, et al. A research agenda for malaria eradication: drugs. PLoS Med 2011;8:e1000402. 37. WHO (2011) Malaria Vaccine Rainbow Tables. http://www.who.int/vaccine_research /links/Rainbow/en/index.html. 38. Ponnudurai T, Lensen AHW, Van Gemert GJ, Bensink MPE, Bolmer M, Meuwissen JH. Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes. Parasitol 1989; 98:165-73. 39. Holder AA. The carboxy-terminus of merozoite surface protein 1: structure, specific antibodies and immunity to malaria. Parasitology 2009; 136:1445-56. 40. Nieman AE, de Mast Q, Roestenberg M, et al. Cardiac complication after experimental human malaria infection: a case report. Malar J 2009; 8:277. 41. de Mast Q, Groot E, Lenting PJ, et al. Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria. J Infect Dis 2007; 196:622-8. 42. Hermsen CC, Telgt DS, Linders EH, et al. Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol. Biochem. Parasitol.2001;118:247-251.
- Page 118 and 119: Chapter 6 Efficacy of pre-erythrocy
- Page 120 and 121: Efficacy of pre-erythrocytic and bl
- Page 122 and 123: Efficacy of pre-erythrocytic and bl
- Page 124 and 125: Efficacy of pre-erythrocytic and bl
- Page 126 and 127: Efficacy of pre-erythrocytic and bl
- Page 128 and 129: Efficacy of pre-erythrocytic and bl
- Page 130 and 131: Chapter 7 NF135.C10: a new Plasmodi
- Page 132 and 133: NF135.C10: a new Plasmodium falcipa
- Page 134 and 135: NF135.C10: a new Plasmodium falcipa
- Page 136 and 137: NF135.C10: a new Plasmodium falcipa
- Page 138 and 139: NF135.C10: a new Plasmodium falcipa
- Page 140 and 141: NF135.C10: a new Plasmodium falcipa
- Page 142 and 143: NF135.C10: a new Plasmodium falcipa
- Page 144 and 145: NF135.C10: a new Plasmodium falcipa
- Page 146 and 147: NF135.C10: a new Plasmodium falcipa
- Page 148 and 149: NF135.C10: a new Plasmodium falcipa
- Page 150 and 151: NF135.C10: a new Plasmodium falcipa
- Page 152 and 153: Chapter 8 Induction of malaria in v
- Page 154 and 155: Induction of malaria in volunteers
- Page 156 and 157: Induction of malaria in volunteers
- Page 158 and 159: Induction of malaria in volunteers
- Page 160 and 161: Induction of malaria in volunteers
- Page 162 and 163: Induction of malaria in volunteers
- Page 164 and 165: Induction of malaria in volunteers
- Page 166 and 167: Induction of malaria in volunteers
- Page 170 and 171: Induction of malaria in volunteers
- Page 172: Section 3 Whole parasite inoculatio
- Page 175 and 176: 174 Chapter 9 Abstract An effective
- Page 177 and 178: 176 Chapter 9 Figure 1. Study desig
- Page 179 and 180: 178 Chapter 9 followed by five iden
- Page 181 and 182: 180 Chapter 9 Figure 2. Parasitemia
- Page 183 and 184: 182 Chapter 9 Test Day I-1 Day C-1
- Page 185 and 186: 184 Chapter 9 strain P. falciparum-
- Page 187 and 188: 186 Chapter 9 protective role in ot
- Page 189 and 190: 188 Chapter 9 References 1. Greenwo
- Page 191 and 192: 190 Chapter 9 27. Orjih AU. Acute m
- Page 193 and 194: 192 Chapter 9 medium A (Caltag Labo
- Page 195 and 196: 194 Chapter 10 Abstract Induction o
- Page 197 and 198: 196 Chapter 10 Pre-erythrocytic sta
- Page 199 and 200: 198 Chapter 10 procedures described
- Page 201 and 202: 200 Chapter 10 by hand-dissection.
- Page 203 and 204: 202 Chapter 10 Figure 3. Mean numbe
- Page 205 and 206: 204 Chapter 10 Figure 4. Number of
- Page 207 and 208: 206 Chapter 10 temperature (Pearson
- Page 209 and 210: 208 Chapter 10 immune modulating ef
- Page 211 and 212: 210 Chapter 10 cytokine measurement
- Page 213 and 214: 212 Chapter 10 14. Hermsen CC, Telg
- Page 216 and 217: Chapter 11 General Discussion
168 Chapter 8<br />
28. Epstein JE, Tewari K, Lyke KE, et al. Live attenuated malaria vaccine designed to<br />
protect through hepatic CD8 T cell immunity. Science 2011; 334:475-480.<br />
29. Church LW, Le TP, Bryan JP, et al. Clinical manifestations of Plasmodium<br />
falciparum malaria experimentally induced by mosquito challenge. J Infect Dis<br />
1997; 175:915-20.<br />
30. Verhage DF, Telgt DS, Bousema JT, et al. Clinical outcome of experimental<br />
human malaria induced by Plasmodium falciparum-infected mosquitoes. Neth J<br />
Med 2005; 63:52-8.<br />
31. Epstein JE, Rao S, Williams F, et al. Safety <strong>and</strong> clinical outcome of experimental<br />
challenge of human volunteers with Plasmodium falciparum-infected<br />
mosquitoes: an update. J Infect Dis 2007; 196:145-54.<br />
32. Rickman LS, Jones TR, Long GW, et al. Plasmodium falciparum-infected<br />
Anopheles stephensi inconsistently transmit malaria to humans. Am J Trop Med<br />
Hyg 1990; 43:441-5.<br />
33. Lyke KE, Laurens M, Adams M, et al. Plasmodium falciparum malaria challenge<br />
by the bite of aseptic Anopheles stephensi mosquitoes: results of a r<strong>and</strong>omized<br />
infectivity trial. PLoS One 2010; 5:e13490.<br />
34. Inoue M & Culleton RL The intradermal route for inoculation of sporozoites of<br />
rodent malaria parasites for immunological studies. Parasite Immunol. 2011;<br />
33:137-142.<br />
35. Fairley NH. Sidelights on malaria in man obtained by subinoculation<br />
experiments. Trans R Soc Trop Med Hyg 1947; 40:621-76.<br />
36. Alonso PL, Djimde A, Kremsner P, et al. A research agenda for malaria<br />
eradication: drugs. PLoS Med 2011;8:e1000402.<br />
37. WHO (2011) Malaria Vaccine Rainbow Tables.<br />
http://www.who.int/vaccine_research /links/Rainbow/en/index.html.<br />
38. Ponnudurai T, Lensen AHW, Van Gemert GJ, Bensink MPE, Bolmer M,<br />
Meuwissen JH. Infectivity of cultured Plasmodium falciparum gametocytes to<br />
mosquitoes. Parasitol 1989; 98:165-73.<br />
39. Holder AA. The carboxy-terminus of merozoite surface protein 1: structure,<br />
specific antibodies <strong>and</strong> immunity to malaria. Parasitology 2009; 136:1445-56.<br />
40. Nieman AE, de Mast Q, Roestenberg M, et al. Cardiac complication after<br />
experimental human malaria <strong>infection</strong>: a case report. Malar J 2009; 8:277.<br />
41. de Mast Q, Groot E, Lenting PJ, et al. Thrombocytopenia <strong>and</strong> release of<br />
activated von Willebr<strong>and</strong> Factor during early Plasmodium falciparum malaria. J<br />
Infect Dis 2007; 196:622-8.<br />
42. Hermsen CC, Telgt DS, Linders EH, et al. Detection of Plasmodium falciparum<br />
malaria parasites in vivo by real-time quantitative PCR. Mol. Biochem.<br />
Parasitol.2001;118:247-251.
Change language